106-120 of 366

Advancing Care in HNSCC: Evolving Strategies Across the Disease Continuum
CME/CEAdvancing Care in HNSCC: Evolving Strategies Across the Disease Continuum

From Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma
CME/CEFrom Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma

Unmet Need: Second-Line Outcomes Remain Poor for NSCLC and Pancreatic Cancer
MinuteCE®Unmet Need: Second-Line Outcomes Remain Poor for NSCLC and Pancreatic Cancer

Early Approaches to RAS Targeting: Efficacy Signals and Known Limitations
MinuteCE®Early Approaches to RAS Targeting: Efficacy Signals and Known Limitations
- advertisement

Mechanistic Evolution in RAS Therapy: ON-State and Multi-Selective Targeting
MinuteCE®Mechanistic Evolution in RAS Therapy: ON-State and Multi-Selective Targeting

NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors
MinuteCE®NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors

Evaluating Use in Pancreatic Cancer: Efficacy and Safety Data for ON-State RAS Inhibitors
MinuteCE®Evaluating Use in Pancreatic Cancer: Efficacy and Safety Data for ON-State RAS Inhibitors

Novel RAS-Targeted Therapy: Prevention, Monitoring, and Mitigation of Adverse Events
MinuteCE®Novel RAS-Targeted Therapy: Prevention, Monitoring, and Mitigation of Adverse Events

RAS(ON) and Beyond: Clinical Integration and Strategic Sequencing
MinuteCE®RAS(ON) and Beyond: Clinical Integration and Strategic Sequencing

Frontline Insights: Emerging Therapeutic Strategies in HNSCC
CME/CEFrontline Insights: Emerging Therapeutic Strategies in HNSCC
- advertisement

Breaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
CME/CEBreaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma

Interdisciplinary Strategies for BRCA-Mutated EBC: Testing, Targeting, and Team-Based Care
CME/CE Broadcast ReplayInterdisciplinary Strategies for BRCA-Mutated EBC: Testing, Targeting, and Team-Based Care

Addressing Unmet Needs in Metastatic Uveal Melanoma
CME/CEAddressing Unmet Needs in Metastatic Uveal Melanoma




































